20.10.2023 • News
EU Commission Approves Pfizer’s Takeover of Seagen
The US pharmaceutical company Pfizer has been cleared to acquire Seagen, a biotech company focused on developing cancer treatments.
Mergers & Acquisitions (M&A)
19.10.2023 • News
PPG Divests Traffic Solutions Operations in Australia and New Zealand
US paints and coatings group PPG has divested all Traffic Solutions operations in Australia and New Zealand to Geveko Markings, a pavement markings specialist headquartered in Sweden. Financial terms of the agreement were not disclosed.
18.10.2023 • News
LyondellBasell Invests in De Paauw Sustainable Resources
LyondellBasell acquired its 50% share from De Paauw Sustainable Resources (DPSR) CEO Roy de Paauw and ING Corporate Investments. DPSR is a plastics waste recycling company based out of the Netherlands.
18.10.2023 • News
Novo Nordisk to Buy Hypertension Treatment from KBP Biosciences
Novo Nordisk has agreed to acquire ocedurenone for uncontrolled hypertension with potential application in cardiovascular and kidney disease from KBP Biosciences for up to $1.3 billion.
16.10.2023 • News
Albemarle Withdraws Bid to Acquire Liontown Resources
US specialty chemicals company Albemarle has announced that it will not pursue a binding agreement to purchase Liontown Resources and has formally withdrawn its non-binding offer.
13.10.2023 • News
Sterling Pharma Solutions Acquires UK CRO NewChem Technologies
Sterling Pharma Solutions has completed the acquisition of UK-based NewChem Technologies, a contract services provider focused on organic chemistry and supplying customers across a range of industries from pharmaceuticals, diagnostics and biotechnology, to veterinary science and chemicals.
12.10.2023 • News
SK Capital Acquires Food Ingredients Company J&K
Private equity group SK Capital Partners has agreed to acquire US company J&K Ingredients, currently owned by Core Industrial Partners.
11.10.2023 • News
ExxonMobil to Buy Pioneer Natural Resources for $60 Billion
The US energy sector is on the verge of a mega merger: energy and petrochemical giant ExxonMobil has announced its intention to take over producer Pioneer Natural Resources. The merger is planned as an all-stock transaction valued at $59.5 billion, or $253 per share, based on ExxonMobil’s closing price on Oct. 5, 2023, according to a company statement. First reports about the ongoing negotiations already circulated last week.
09.10.2023 • News
Bristol-Myers Squibb to Acquire Mirati for up to $5.8 Billion
Bristol-Myers Squibb (BMS) announced that it will acquire Mirati Therapeutics for up to $5.8 billion. BMS is to pay $58.00 per share in cash, for a total equity value of $4.8 billion, diversifying its oncology business and adding drugs it hopes can help offset expected lost revenue from patent expirations later this decade.
05.10.2023 • News
Kensing Acquires Advanced Organic Materials (AOM)
Kensing, a manufacturer of natural vitamin E, plant sterols, and high-purity surfactants, announced the acquisition of Advanced Organic Materials (AOM), a producer of non-GMO plant-based vitamin E and phytosterols derived from sunflower and rapeseed.
04.10.2023 • News
Eli Lilly to Acquire Radiopharmaceutical Company Point Biopharma for $1.4 Billion
Eli Lilly announced that it is acquiring radiopharmaceutical company Point Biopharma for $12.50 per share in cash, valuing the deal at approximately $1.4 billion. Point has pipeline of clinical and preclinical-stage radioligand therapies in development for the treatment of cancer. The transaction has been approved by the boards of directors of both Indianapolis-based US companies.
29.09.2023 • News
Ineos Acquires the Eastman Texas City Site
Petrochemicals giant Ineos has agreed to buy compatriot Eastman’s Texas City site, including the 600 kt acetic acid plant and all associated third party activities on the site, for about $500 million.
26.09.2023 • News
India’s Nirma to Buy API Producer Glenmark Life Sciences
Indian drugmaker Glenmark Pharma has agreed to sell 75% of the shares in its subsidiary Glenmark Life Sciences (GLS) to detergent manufacturer Nirma for 56.515 million Indian rupees (about €639.000).
25.09.2023 • News
Novo Holdings, Gurnet Point Close Acquisition of Paratek Pharmaceuticals
Novo Holdings, controlling shareholder in drugmaker Novo Nordisk, and healthcare investment firm Gurnet Point closed their acquisition of US antibiotics specialist Paratek Pharmaceuticals in a transaction valued at $462 million. Novo Holdings said that this is its largest individual investment in antimicrobial resistance (AMR) therapies to date.
22.09.2023 • News
Ineos Acquires Eramet Titanium & Iron for €230 Million
Ineos Enterprises has announced the acquisition of Eramet Titanium & Iron (ETI) from Eramet for €230 million ($245 million). The deal was completed on Sept. 21 and takes immediate effect, following the satisfaction of regulatory approvals.
15.09.2023 • News
MOL Chemical Tankers to Buy Fairfield Chemical Carriers
Singapore-headquartered shipping company MOL Chemical Tankers has agreed to acquire the business of Fairfield Chemical Carriers, a subsidiary of Fairfield-Maxwell, in an all-cash transaction for about $400 million.
08.09.2023 • News
Univar Buys Canadian Chemicals Distributor FloChem
US specialty ingredients and chemicals distributor Univar Solutions has acquired Canadian company FloChem and certain of its affiliates, giving Univar access to new market segments and new service capabilities. Terms of the transaction were not disclosed.
05.09.2023 • News
Albemarle Makes Final Proposal for the Acquisition of Liontown
Australian lithium miner Liontown announced that it has received a revised conditional and non-binding indicative proposal from Albemarle to acquire all of the ordinary shares outstanding in Liontown for A$3.00 in cash per share via scheme of arrangement. The revised proposal values Liontown at A$6.6 billion ($4.3 billion) on an equity value basis.
05.09.2023 • News
FTC Approves Amgen's Acquisition of Horizon
The US Federal Trade Commission (FTC) wants to clear the takeover of Irish biotech company Horizon Therapeutics by pharmaceutical group Amgen. Following concessions by Amgen, the authority is dropping its earlier objections to the $27.8 billion purchase, the FTC announced last Friday.
04.09.2023 • News
Danaher to Acquire Abcam for $5.7 Billion
US science and technology group Danaher has entered into a definitive agreement to acquire Abcam, a supplier of life science research tools. Danaher will buy all of the outstanding shares of Abcam for $24.00 per share. The transaction, which is worth about $5.7 billion, is expected to close in mid-2024.
29.08.2023 • News
EuroAPI to Acquire German CDMO BianoGMP
Active pharmaceutical ingredients manufacturer EuroAPI has agreed to acquire BianoGMP, a contract development and manufacturing organization (CDMO) specializing in oligonucleotides. Biano is to become a EuroAPI company but retain its corporate brand.
23.08.2023 • News
DuPont to Divest Majority Stake in Delrin Business to TJC
DuPont has agreed to sell an 80.1% ownership interest in the Delrin acetal homopolymer (H-POM) business to private equity company TJC in a transaction valuing the business at $1.8 billion. The transaction is expected to close around year-end 2023, subject to customary closing conditions and regulatory approval.
21.08.2023 • News
Thermo Fisher Completes Acquisition of CorEvitas
Thermo Fisher Scientific has completed the acquisition of CorEvitas, a provider of registry data and analytic services, from Audax Private Equity for $912.5 million in cash.
16.08.2023 • News
Occidental to Acquire Carbon Engineering for $1.1 Billion
US oil and gas producer Occidental Petroleum has agreed to acquire Canadian climate solutions company Carbon Engineering for $1.1 billion, a developer of technology for large-scale direct air capture (DAC).
11.08.2023 • News
Novo Nordisk to Acquire Inversago Pharma
Danish drugmaker Novo Nordisk has agreed to acquire Montreal, Canada-based Inversago Pharma. The transaction is worth up to $1.075 billion in cash if certain development and commercial milestones are achieved, the companies said in a statement.
09.08.2023 • News
Investor EQT Sells Schülke to a Consortium Led by Athos
Swedish venture capital firm EQT is selling pharmaceutical company Schülke & Mayr to a consortium led by Athos, the family office of Hexal founders and Biontech shareholders Andreas and Thomas Strüngmann.
02.08.2023 • News
AkzoNobel Completes Acquisition of Sherwin-Williams’ Chinese Decorative Paints Business
AkzoNobel has completed the acquisition of Sherwin-Williams’ Chinese decorative paints business, including the widely known Chinese Huarun brand.
01.08.2023 • News
IMCD Acquires Puerto Rican Distributor Sachs Chemical
Rotterdam-based specialty chemicals distributor IMCD has agreed to acquire 100% of the shares of Sachs Chemical, headquartered in San Juan, Puerto Rico.
31.07.2023 • News
Biogen Acquires Reata Pharmaceuticals
Biogen and Reata Pharmaceuticals announced late last week that Biogen has agreed to acquire Reata for €156.51 per share in cash, reflecting an enterprise value of approximately €6.6 billion.
31.07.2023 • News
AstraZeneca Acquires Early-stage Gene Therapies from Pfizer
Alexion, AstraZeneca's rare disease division, has agreed to buy a portfolio of preclinical gene therapy programs and enabling technologies from competitor Pfizer for up to $1 billion, plus tiered royalties on sales.
28.07.2023 • News
Roquette to Acquire Qualicaps
French plant ingredients supplier Roquette, which is also is a leading player in naturally-derived pharmaceutical excipients, has agreed to acquire Qualicaps, a producer of hard capsules and pharmaceutical processing equipment for oral dosage.
24.07.2023 • News
SK Biopharmaceuticals Aims to Become 'Big Biotech'
SK Biopharmaceuticals, a South Korean-based biotech, has announced its new strategy to propel the company towards becoming a global “big biotech.”
21.07.2023 • News
Zeta Acquires 20% Stake in CB Consultancy
Zeta, an Austrian engineering specialist for biopharmaceutical process plants, acquired a 20% share in Swiss company CB Consultancy. The transaction was completed by Jul. 14, 2023.
17.07.2023 • News
Lilly to Acquire Obesity Drug Maker Versanis
Major drugmaker Eli Lilly has agreed to acquire Versanis Bio, a privately held obesity drug maker, for up to $1.925 billion. The transaction is subject to customary closing conditions.
14.07.2023 • News
ExxonMobil Acquires Denbury Valued at €4.5 Billion
ExxonMobil has acquired Denbury, a carbon capture, utilization, and storage (CCUS) and enhanced oil recovery company. The all-stock transaction is valued at €4.5 billion.
